<div><strong>The day after my son's first birthday, I was diagnosed with a brain tumour - Glioblastoma grade IV. Please help me raise money for vital treatment.</strong>
</div>
<div><br />
</div>
<div><strong>My story.</strong>
</div>
<div><br />
</div>
<div>Four years ago, I married Jess, the love of my life. A year ago we were blessed with our wonderful son, Aein. Life was full of joy, and the future couldn’t have looked brighter.
</div>
<div><br />
</div>
<div>A day after my son's first birthday, I was diagnosed with a brain tumour. My MRI showed a Grade IV primary glioblastoma—a highly aggressive and rare cancer, especially for someone my age. I’m only 42.
</div>
<div><br />
</div>
<div>I underwent urgent brain surgery at the John Radcliffe, where a brilliant team managed to remove 95% of the tumour. I’m half way through six weeks of combined chemotherapy and radiotherapy, the current standard treatment.
</div>
<div><br />
</div>
<div>Glioblastomas are notoriously resistant. They infiltrate healthy brain tissue, making it impossible to remove them entirely, and even after surgery and chemo-radiation, left unchecked the cancer always returns.
</div>
<div><br />
</div>
<div>But there are many patients living with stable tumours leading normal lives.
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>Why I’m fundraising.</strong>
</div>
<div><br />
</div>
<div>Glioblastoma is so rare that it receives little state funding and almost no private investment.
</div>
<div><br />
</div>
<div>In fact, despite the amazing care I’m getting from my NHS team, the standard NHS treatment hasn’t changed for 20 years. Fortunately, international centres are now offering promising approaches and new clinical trials are starting all the time, leading to many long-term survivors living relatively normal lives.
</div>
<div><br />
</div>
<div>I’m young, I’m fit, I have everything to live for and the support of a loving network of family and friends - statistically all of these will help me reach long term survival. I want to be Aein’s dad and Jess’s husband for as long as I possibly can. And who knows, thanks to breakthroughs in fields like AI and personalised medicine, there may yet be more options on the horizon that can contain these tumours indefinitely.
</div>
<div><br />
</div>
<div><strong>I just need time.</strong>
</div>
<div><br />
</div>
<div>With your help I want to access treatments not available in the UK that could give me a real fighting chance.
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>Promising Options We’re Exploring</strong>
</div>
<div><br />
</div>
<div>I’ve already had incredible support from friends and family. People have spent many hours researching potential treatments and contacting experts who might be able to help.
</div>
<div><br />
</div>
<div>The research consistently points to<strong> individualised treatment</strong> giving me the best chance of longer survival, with detailed tumour analysis and collaboration with the best clinicians, wherever in the world that may be.
</div>
<div><br />
</div>
<div><strong>Some of the most promising include:</strong>
</div>
<ul>
<li><strong>Tumour Treating Fields (TTF)</strong>: Clinically proven to extend survival, but means wearing a cap hooked up to batteries for 18 hours a day. TTF uses alternating electric fields to disrupt cancer cell division and is standard treatment in the US and Germany (but not in the NHS).
</li>
<li><strong>Dendritic Cell Vaccine Therapy</strong>: New but promising personalised immunotherapy that trains the immune system to recognise and attack glioblastomas, Germany is the European leader and commonly offers the treatment as part of a personal plan.
</li>
<li>M<strong>olecular Profiling + Individualised Therapies</strong>: These enable tailored treatments based on my tumour’s unique DNA, again used in Germany to build an individualised treatment plan offering better-targeted, potentially more effective options.
</li>
<li><strong>Immunogenic Cell Death Induction (ICD)</strong>: A promising treatment that enhances the effectiveness of other therapies by priming the immune system.
</li>
<li><strong>Oncothermia (Modulated electro-hyperthermia)</strong>: An established complementary therapy used alongside conventional treatments to potentially enhance drug uptake and stimulate anti-tumour immune responses.
</li>
</ul>
<div><br />
</div>
<div>I'm still waiting for formal recommendations and quotes from UK and German specialists, but here’s what I know so far. I’ll update this page regularly with any developments and will be fully transparent about how funds are used.
</div>
<div><br />
</div>
<div><strong>Estimated Costs</strong>
</div>
<ul>
<li><strong>Dendritic cell vaccine</strong> – Full course: £20k+, or DCVax-1: £200k
</li>
<li><strong>Tumour Treating Fields (TTF)</strong> – Approx. £15,000–£20,000 per month, typically for 6–12 months. Total: £100k+
</li>
<li><strong>Immunogenic Cell Death Induction</strong>, approx. £5,000–£10,000 per cycle (possibly 4–5 cycles). Total: £25k–£50k
</li>
<li><strong>Oncothermia with Vitamin C</strong> – Approx. £5,000 per cycle (4 cycles are usual)
</li>
<li><strong>Accommodation and travel</strong> – Estimated at £20,000+
</li>
</ul>
<div><br />
</div>
<div><strong>Total estimate £200,000 to £300,000.</strong>
</div>
<div><br />
</div>
<div>With the support of friends and family, we’re funding what we can. But the truth is, we can’t do this without your help.
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>How You Can Help</strong>
</div>
<div><br />
</div>
<div>If you’re able to contribute, no matter the amount, it means everything to us. <strong>Each and every donation – even if it’s the price of a pint or a coffee - brings us closer to life-extending treatment.</strong>
</div>
<div><br />
</div>
<div>Even if you can’t afford to spare anything, you can help me just by <strong>sharing this page. </strong>You’ll be helping give me a real chance to watch my son grow up, to walk beside Jess through the life we built together, and to fight this disease with every tool possible. I’m so grateful for anything you can manage.
</div>
<div><br />
</div>
<div><strong>THANK YOU</strong>
</div>
<div><br />
</div>
<div>Thank you for reading, for sharing, and for being part of this journey.
</div>
<div><br />
</div>
<div>With love and gratitude,
</div>
<div>Elliot
</div>

Daniel Nembhard

Chris Laughton

Rob Jackson

David Farrell

Jamie Watson

Jamie Padginton

Duane Ellis

Caron McDonagh

Ste Magee

Alex Nahai

Luke Cowham

Anonymous

Natasha Feldman

russell  jenny godfrey

Chantelle Segafredo

sue thomas

Help Elliot fight brain cancer

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Help Elliot fight brain cancer

Still £28,098 to go. Help us build momentum.